Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
This study is designed to establish the foundation for a new therapy for neurofibromatosis Type I (NF1)-related cutaneous neurofibromas (cNFs) by assessing the…
NF1NeurofibromatosisCutaneous Neurofibroma+3 more
Johns Hopkins UniversityNCT07102394
Phase 1
A Phase 1/2a Open-label, Multicenter Dose Finding Study to Evaluate the Safety and Anti-tumor Activity of Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
This is a Phase 1/2a, open-label, non-randomized, multi-dose study of mirdametinib monotherapy in adults with NF1 and cNF. In both Phases of the study, partic…
NF1Cutaneous NeurofibromaMonotherapy
Johns Hopkins UniversityNCT06159166